跳到正文
Emil Lou, MD, PhD, FACP, FASCO· @cancerassassin1 · X·· 2026-04-19评分60
正文 · 原文

…2. Altered immune microenvironments: legitimate opportunities to pair with IO?
3. And mechanisms of Resistance… because RAS *will* fight back. (And be sure to thank biochemists, pharmacologists, and many others). seek answers at #AACR26 and beyond #AACR27 #AACR28 #AACR29 2/2

热度 6 · 6 赞 · 0 回复 · 0 转发

来源:Emil Lou, MD, PhD, FACP, FASCO · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org